Kevin Kalinsky
MD, MS
Dr. Kalinsky treats patients diagnosed with breast cancer at Winship Cancer Institute Clifton campus and Winship Cancer Institute at Emory Midtown.
Titles and Roles
- Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Louisa and Rand Glenn Family Chair in Breast Cancer Research
- Winship Cancer Institute of Emory University
- Director, Glenn Family Breast Center
- Winship Cancer Institute of Emory University
- Director, Division of Medical Oncology, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Director, Breast Medical Oncology
- Winship Cancer Institute of Emory University
- Medical Oncologist
- Breast Cancer
- Phase I Clinical Trials Unit
- Cardio-Oncology Clinic
- Research Program
- Discovery and Developmental Therapeutics
Biography
Kevin Kalinsky, MD, MS, is professor and medical oncology division director in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Kalinsky serves as the director of the Glenn Family Breast Center at Winship where he is tasked with fulfilling the vision to improve breast cancer outcomes by aligning research and education with cancer treatment and prevention. A breast cancer physician and investigator, Dr. Kalinsky's research focus is in developing new therapeutic approaches to patients with breast cancer.
Dr. Kalinsky is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University.
Education
Dr. Kalinsky received his medical degree from the Medical University of South Carolina and a Masters in Biostatistics, Patient Oriented Research Track from Columbia University Mailman School of Public Health. His training included a Residency and Medical Oncology Fellowship at Tufts-New England Medical Center, Breast Cancer Research Fellowship at Massachusetts General Hospital, and Breast Cancer Advanced Oncology Fellowship at Memorial Sloan-Kettering Cancer Center.
Research
Dr. Kalinsky's research is in the area of new drug development and therapies for patients with early stage and metastatic breast cancer. His work involves the development clinical trials to assess novel therapeutic agents in breast cancer based on tumor genomics. He is funded by a number of sources, including the National Institutes of Health and the Breast Cancer Research Foundation.
Publications
Publications Publication Date
Awards
Dr. Kalinsky is a recipient of the Ewig Clinical Scholar Teaching Award from Columbia University, NCI Cancer Clinical Investigator Team Leadership Award, Physician of Impact Award from Susan G. Komen Greater NYC, and SWOG Career Engagement Award.